NOTICE OF INTENT TO SOLE SOURCE - Trailtrove.docx
DOCX document 19 KB Posted
- Attached to
- NOTICE OF INTENT TO SOLE SOURCE – COMBINED SYNOPSIS/SOLICITATION - Trialtrove+ Subscription
- Solicitation number
- FDA-CITELINE-1292051
About this file
This is a Notice of Intent to Sole Source combined with a Synopsis-Solicitation for commercial products and services. The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Administration, intends to award a sole-source purchase order to Caerus US 1 Inc. for access to Citeline Trialtrove+ Subscription services. The solicitation number is 7571TE26P00155, with a NAICS code of 513210. The anticipated period of performance runs from September 30, 2026 through September 29, 2027. HHS requires access to Citeline data and related subscription services to support the requirements outlined in the attached Statement of Work. The contracting officer has determined that Caerus US 1 Inc. is the sole source capable of providing the required Citeline subscription and data services based on market research.
Responses from interested sources must be submitted electronically to Contracting Officer Saundra Little Kpadeh at Saundra.Kpadeh@hhs.gov by September 25, 2026 at 3:00 PM Eastern Time. Capability statements should not exceed five double-spaced pages and must include company information (name, UEI, CAGE code, business size), a description of the proposed product or service, evidence of meeting requirements, identification of any material differences from the Citeline products, pricing information, and a point of contact. Questions must be submitted by September 24, 2026 at 10:00 AM EST. The quotation validity period is 30 days, and a binding contract is formed when the contractor accepts the purchase order in writing or begins performance. The government reserves the right to proceed with the sole-source award or conduct a competitive procurement based on responses received.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Trialtrove Software Statement of Work (2026-09-23).docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
NOTICE OF INTENT TO SOLE SOURCE / COMBINED SYNOPSIS-SOLICITATION
Solicitation No.: 7571TE26P00155 Agency: U.S. Department of Health and Human Services Office: HHS/ASFR/OMAS NAICS Code: 513210
PSC:
Response Date: September 25, 2026 at 3:00pm EST
1. Notice This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12, Acquisition of Commercial Products and Commercial Services, and FAR Part 13, Simplified Acquisition Procedures, as supplemented with additional information included in this notice.
This announcement constitutes the only solicitation. A separate written solicitation will not be issued.
The U.S. Department of Health and Human Services (HHS), ASFR/OMAS, intends to negotiate and award a sole-source purchase order to Caerus US 1 Inc. for access to Citeline Trialtrove+ Subscription], subject to consideration of any responses received as a result of this notice.
2. Requirement HHS requires access to Citeline data and related subscription services to support requirements in Attachment# 1 Statement of Work.
The anticipated Period of Performance is September 30, 2026 to September 29, 2027.
3. Sole-Source Basis The Government intends to solicit and negotiate with only one source pursuant to FAR 13.106-1(b), based on the contracting officer's determination that the circumstances of the acquisition support solicitation from a single source.
The Government's market research indicates that Caerus US 1 Inc. is the source capable of providing the required Citeline subscription/data services meeting the Government's identified requirements.
The Government's supporting single-source documentation will be maintained in the contract file and posted when required by applicable acquisition regulations.
4. Notice to Interested Sources This notice of intent is not a request for competitive quotations. However, responsible sources that believe they can satisfy the Government's requirement may submit a capability statement and supporting information demonstrating their ability to meet the requirement.
Responses must contain sufficient information for the Government to determine whether the respondent can provide the required products/services, including:
1. Company name, UEI, CAGE code, and business size/socioeconomic status;
2. Description of the proposed product or service;
3. Evidence demonstrating that the proposed solution satisfies the Government's requirements;
4. Identification of any material differences between the proposed solution and the Citeline products identified above;
5. Pricing or other information requested by the Contracting Officer; and
6. Authorized point of contact.
The Government will consider information received by the response deadline solely for the purpose of determining whether conducting a competitive procurement is appropriate.
5. Commercial Acquisition Provisions and Clauses The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01.
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Products and Commercial Services, applies to this acquisition.
Questions and Clarifications:
Submit questions by September 24, 2026 at 10:00am EST to Saundra.Kpadeh@hhs.gov. Identify the RFQ number and Title “Trialtrove+ Subscription”. The Government may consolidate and answer questions by amendment. Questions received after the deadline may not receive a response.
The clause at FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services, applies to this acquisition.
The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Products and Commercial Services, applies to this acquisition, including the applicable clauses identified by the Contracting Officer.
6. Submission Instructions Responses shall be submitted electronically to:
Contracting Officer/Specialist: Saundra Little Kpadeh Email: Saundra.Kpadeh@hhs.gov Deadline: September 25, 2026 @ 3:00pm Eastern Time (EST).
Responses to the Attachment#1: Statement of Work should be limited to no more than five (5) double-spaced pages. Page size is 8.5 x 11 inches with 1-inch margins. Cover page, table of contents, and cover letter will be excluded from the page limit. Text must be a minimum font size/style of 10-point Times New Roman. Tables must be a minimum font size/style of 9-point in the Arial family. Graphics must be at minimum 8-point in the Arial family. Tables and Graphics may use the landscape format. All other text must use the portrait format.
Quotation Validity Period is 30 days.
A quotation is not an offer that the Government may accept to form a binding contract. A purchase order issued in response to a quotation is the Government’s offer. A binding contract is formed when the contractor accepts the purchase order in writing or begins performance, as provided in RFO FAR 12.201-1.
Responses received after the stated deadline may not be considered.
Issuance of this notice does not obligate the Government to award a contract, pay costs incurred in preparing a response, or otherwise reimburse respondents for information submitted.
Following consideration of any timely responses, the Government may proceed with the intended sole-source award if the Contracting Officer determines that doing so is appropriate.
File details come from the government source that posted it. Updated .